Pfizer | 8-K: Current report
Pfizer | 8-K: Cyrus Taraporevala Elected to Pfizer's Board of Directors
Pfizer | 8-K: Current report
Pfizer | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pfizer | 8-K: Pfizer Reports First-Quarter 2024 Results
Pfizer | 8-K: Poll Results of Pfizer Meeting
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEF 14A: Definitive information statements
Pfizer | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pfizer | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Pfizer | 8-K: Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
Pfizer | 8-K: Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
Pfizer | 8-K/A: Pfizer Completes Acquisition of Seagen
Pfizer | 8-K: Pfizer Completes Acquisition of Seagen
No Data